Growth Metrics

Cytosorbents (CTSO) Cash from Investing Activities (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 84.19%
Dec 31, 2025 -629.09%
Sep 30, 2025 141.67%
Jun 30, 2025 -180.85%
Mar 31, 2025 62.10%
Dec 31, 2024 58.53%
Sep 30, 2024 -151.30%
Jun 30, 2024 6.33%
Mar 31, 2024 6.55%
Dec 31, 2023 47.26%
Sep 30, 2023 -283.71%
Jun 30, 2023 120.54%
Mar 31, 2023 -231.37%
Dec 31, 2022 71.24%
Sep 30, 2022 84.71%
Jun 30, 2022 -452.51%
Mar 31, 2022 49.31%
Dec 31, 2021 -64.40%
Sep 30, 2021 -3.33%
Jun 30, 2021 -62.40%
Mar 31, 2021 -127.83%
Dec 31, 2020 34.15%
Sep 30, 2020 18.74%
Jun 30, 2020 2.20%
Mar 31, 2020 -26.12%
Dec 31, 2019 -27.86%
Sep 30, 2019 3.65%
Jun 30, 2019 30.98%
Mar 31, 2019 -46.62%
Dec 31, 2018 -17.11%
Sep 30, 2018 38.40%
Jun 30, 2018 5.06%
Mar 31, 2018 18.85%
Dec 31, 2017 -7.94%
Sep 30, 2017 -52.94%
Jun 30, 2017 -72.42%
Mar 31, 2017 -108.27%
Dec 31, 2016 -257.38%
Sep 30, 2016 -96.94%
Jun 30, 2016 603.11%
Mar 31, 2016 13.52%
Dec 31, 2015 -144.23%
Sep 30, 2015 405.30%
Jun 30, 2015 69.44%
Mar 31, 2015 -121.76%
Dec 31, 2014 295.68%
Sep 30, 2014 -2,841.78%
Jun 30, 2014 98.10%
Mar 31, 2014 -2,805.21%
Dec 31, 2013 -876.39%
Sep 30, 2013 49.24%
Jun 30, 2013 -1,415.65%
Mar 31, 2013 87.75%
Dec 31, 2012 -452.40%
Sep 30, 2012 134.36%
Jun 30, 2012 -30.69%
Mar 31, 2012 -1,928.78%
Dec 31, 2011 97.64%
Dec 31, 2010 -1,792.11%